Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Javier
Díez Martínez
Publicaciones en las que colabora con Javier Díez Martínez (192)
2024
2023
-
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Molecular Aspects of Medicine, Vol. 93
-
Prediction of Left Ventricular Reverse Remodeling and Outcomes by Circulating Collagen-Derived Peptides
JACC: Heart Failure, Vol. 11, Núm. 1, pp. 58-72
-
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study
Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
-
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial
European Journal of Heart Failure, Vol. 24, Núm. 2, pp. 321-331
-
Functional and structural reverse myocardial remodeling following transcatheter aortic valve replacement: a prospective cardiovascular magnetic resonance study
Journal of Cardiovascular Magnetic Resonance, Vol. 24, Núm. 1
-
Heart failure in chronic kidney disease: The emerging role of myocardial fibrosis
Nephrology Dialysis Transplantation, Vol. 37, Núm. 5, pp. 817-824
2021
-
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches
Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498
-
Galectin-3 Inhibition With Modified Citrus Pectin in Hypertension
JACC: Basic to Translational Science, Vol. 6, Núm. 1, pp. 12-21
2020
-
Author Correction: MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Scientific Reports, (2017), 7, 1, (40696), 10.1038/srep40696)
Scientific Reports
-
Burden and challenges of heart failure in patients with chronic kidney disease. A call to action
Nefrologia, Vol. 40, Núm. 3, pp. 223-236
-
Cardiac magnetic resonance-derived fibrosis, strain and molecular biomarkers of fibrosis in hypertensive heart disease
Journal of hypertension, Vol. 38, Núm. 10, pp. 2036-2042
-
Cardiorenal interaction and heart failure outcomes. A role for insulin-like growth factor binding protein 2?
Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 835-843
-
Does chronic kidney disease facilitate malignant myocardial fibrosis in heart failure with preserved ejection fraction of hypertensive origin?
Journal of Clinical Medicine, Vol. 9, Núm. 2
-
Hypertrophic cardiomyopathy in myosin-binding protein C (MYBPC3) Icelandic founder mutation carriers
Open Heart, Vol. 7, Núm. 1
-
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Circulation, Vol. 141, Núm. 9, pp. 751-767
-
Reprint of “The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking”
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1867, Núm. 3